| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.048 | 0.4 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |